“Sales of Teribone Can Reach ¥10 Bil.”: President Asano of Asahi Kasei Pharma

Toshio Asano, President & Representative Director, Asahi Kasei Pharma Asahi Kasei Pharma will aggressively promote Teribone (teriparatide), a treatment for osteoporosis approved in September, in the growing osteoporosis market. In a press conference in Tokyo on October 24, President and...read more